Valuation: Photocure ASA

Market Cap 1.49B 156M 137M 127M 117M 219M 15B 223M 1.51B 590M 7.38B 585M 572M 25.5B P/E 2026 *
16.5x
P/E 2027 * 34.8x
Enterprise Value 1.29B 135M 118M 110M 101M 190M 12.97B 193M 1.31B 510M 6.37B 505M 495M 22.04B EV / Sales 2026 *
1.96x
EV / Sales 2027 * 1.91x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day+2.67%
Current month-2.87%
1 month-4.16%
3 months-17.48%
6 months-20.00%
Current year-19.33%
1 week 54.8
Extreme 54.8
58.1
1 month 54.8
Extreme 54.8
61.8
Current year 54.8
Extreme 54.8
79.8
1 year 50.5
Extreme 50.5
79.8
3 years 40.7
Extreme 40.7
79.8
5 years 40.7
Extreme 40.7
145
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 01/11/2018
Chief Tech/Sci/R&D Officer - 01/08/2021
Human Resources Officer - 01/02/2021
Director TitleAgeSince
Chairman - 27/09/2023
Director/Board Member - 01/01/2022
Director/Board Member - 23/05/2024
Date Insider Type Main position Quantity % Market Cap.
02/04/25 BuyCompany 11,355 0.0419%
02/04/25 BuyCompany 8,997 0.0332%
31/03/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
+2.67%0.00%-6.80%+23.47% 156M
+0.86%+1.43%+47.17%+163.68% 1,067B
+1.59%+4.09%+56.51%+52.50% 635B
+0.95%+1.91%+36.30%+82.78% 458B
+1.51%+8.50%+38.10%+32.10% 347B
+1.49%+4.53%+37.86%+41.80% 295B
+1.61%+4.18%+19.54%+20.54% 262B
+1.14%-1.11%-28.11%-39.05% 216B
+1.22%+2.66%+22.66%+59.87% 203B
-1.18%-3.70%+11.28%+67.52% 161B
Average +0.91%+0.92%+23.45%+50.52% 364.37B
Weighted average by Cap. +0.55%+1.95%+36.41%+79.39%

Financials

2026 *2027 *
Net sales 660M 68.85M 60.47M 56.24M 51.61M 96.96M 6.63B 98.46M 668M 261M 3.26B 258M 253M 11.27B 665M 69.37M 60.93M 56.66M 52M 97.7M 6.68B 99.2M 673M 263M 3.28B 260M 255M 11.36B
Net income 91.33M 9.53M 8.37M 7.79M 7.15M 13.43M 918M 13.63M 92.46M 36.12M 451M 35.79M 35.02M 1.56B 43.33M 4.52M 3.97M 3.69M 3.39M 6.37M 436M 6.47M 43.87M 17.14M 214M 16.98M 16.61M 740M
Net Debt -203M -21.15M -18.58M -17.28M -15.85M -29.79M -2.04B -30.25M -205M -80.16M -1B -79.41M -77.7M -3.46B -221M -23.1M -20.29M -18.87M -17.32M -32.53M -2.22B -33.04M -224M -87.54M -1.09B -86.72M -84.85M -3.78B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
27/07/26 NOK 57.60 +2.67% 17,434
24/07/26 NOK 56.10 -0.53% 15,419
23/07/26 NOK 56.40 +0.18% 15,354
22/07/26 NOK 56.30 0.00% 48,088
21/07/26 NOK 56.30 -2.26% 84,627
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
56.10NOK
Average target price
84.00NOK
Spread / Average Target
+49.73%

Quarterly revenue - Rate of surprise